SCHEMBL3082199

SCHEMBL3082199

CCOC(=O)c1nc2ccccn2c1-c1ccnc(N(C)C)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.51
PTGS2 P35354 1/20 0.51
MAPK1 P28482 2/20 0.48
NTRK1 P04629 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
KDM4E B2RXH2 4/20 0.44
HSD17B10 Q99714 2/20 0.44
MAPT P10636 1/20 0.44
HTT P42858 1/20 0.44
PDE4A P27815 1/20 0.42
ALDH1A1 P00352 6/20 0.41
USP7 Q93009 1/20 0.41
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.40
DGAT1 O75907 1/20 0.40
SOAT1 P35610 1/20 0.40
CSNK1D P48730 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3087167 0.87 PTGS1 (0.52) PTGS1PTGS2MAPK1NTRK1CYP1A2
SCHEMBL3076063 0.85 PTGS1 (0.53) PTGS1PTGS2MAPK1NTRK1CYP1A2
SCHEMBL3080749 0.82 PTGS1 (0.59) PTGS1PTGS2MAPK1NTRK1CYP1A2
SCHEMBL10679185 0.81 CYP2C9 (0.65) PTGS1PTGS2MAPK1NTRK1CYP1A2
SCHEMBL3082291 0.79 PTGS1 (0.48) PTGS1PTGS2MAPK1NTRK1CYP1A2
SCHEMBL3081756 0.79 PIK3CA (0.57) PTGS1PTGS2MAPK1NTRK1CYP1A2
SCHEMBL3072062 0.78 PTGS1 (0.56) PTGS1PTGS2MAPK1NTRK1CYP1A2
SCHEMBL3076257 0.77 USP7 (0.43) SMN1; SMN2KDM4EMAPTHTTALDH1A1
SCHEMBL3076322 0.76 PTGS1 (0.54) PTGS1PTGS2MAPK1NTRK1CYP1A2
SCHEMBL3082054 0.75 USP7 (0.41) SMN1; SMN2KDM4EMAPTHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100227880-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION 2010-09-09 US disclosed
EP-1984375-A2 CHEMICAL COMPOUNDS Smithkline Beecham Corporation (US) 2008-10-29 EP disclosed
WO-2007087548-A9 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2007-09-27 WO disclosed
WO-2007087548-A2 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2007-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100227880-A1 CHEMICAL COMPOUNDS CYP3A5, SLC10A1, ABCB11 PTGS1 504/4885PTGS2 842/4885MAPK1 2628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.